| Sources | Names Used |
|---|---|
| GDSC1000 | KIN001-102 |
| PharmacoGx | KIN001-102 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TES | GDSC1000 | pan-cancer | AAC | -0.097 | 0.005 |
| mRNA | KIAA1456 | GDSC1000 | pan-cancer | AAC | 0.096 | 0.005 |
| mRNA | FOXRED1 | GDSC1000 | pan-cancer | AAC | 0.085 | 0.005 |
| mRNA | SLC35F5 | GDSC1000 | pan-cancer | AAC | -0.093 | 0.005 |
| mRNA | ZNF416 | GDSC1000 | pan-cancer | AAC | 0.081 | 0.005 |
| mRNA | LDLRAD2 | GDSC1000 | pan-cancer | AAC | -0.084 | 0.005 |
| mRNA | IFNA2 | GDSC1000 | pan-cancer | AAC | 0.08 | 0.005 |
| mRNA | RNF13 | GDSC1000 | pan-cancer | AAC | -0.085 | 0.005 |
| mRNA | VANGL2 | GDSC1000 | pan-cancer | AAC | 0.089 | 0.005 |
| mRNA | ELL | GDSC1000 | pan-cancer | AAC | -0.095 | 0.005 |
